Biomedical subjects

E Baldini

Publications and source records attributed to E Baldini.

At least 73 records · Page 4Linked to original sources

PubMed1988

Absence of antibodies to HTLV-I and HIV in serum and cerebrospinal fluid of Italian patients with multiple sclerosis.

Because of the undecided question whether HTLV-related virus antibodies are present in multiple sclerosis (MS), we tested cerebrospinal fluid (CSF) and serum from 52 MS patients and 32 patients affected with other neurological diseases. ELISA procedure was used to detect antibodies against HTLV-I and HIV. Negative results were obtained in all samples examined.

Adult↗

PubMed1985

[Immunohepatologic and clinical monitoring of neuramide therapy in acute viral hepatitis B].

The authors carried out a double blind therapeutic trial with neuramide in 20 drug addicts affected by acute type B anti-delta negative viral hepatitis. The H/S ratio together with the most important clinical and hepatological parameters seem to improve following treatment.

Adolescent↗

PubMed1985

[Comparative evaluation of the diagnostic specificity and sensitivity of third generation tests by the detection of hepatitis B virus markers in the serum. I. HBsAg].

The authors have evaluated comparatively the diagnostic reliability of the most recent RIA and ELISA mono-polyclonal techniques for the determination of HBsAg in serum by means of in vivo and in vitro tests. Statistically, no difference has been found as regards the various methods.

Enzyme-Linked Immunosorbent Assay↗

PubMed1984

[Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].

The authors carried out a controlled therapeutic trial with Thymostimulin in 43 drug addicts affected by acute type B anti-Delta negative viral hepatitis. Both clinical and immunological picture seem to improve following treatment.

Adolescent↗

PubMed1984

[Determination of antibody titers in subjects passively immunized with specific anti-hepatitis B gamma globulins].

The authors have evaluated the effects of specific Immunoglobulins administration in order to prevent type B viral hepatitis. 34 members of care units entered a program of epidemiological surveillance after an occasional contamination with biological samples obtained from patients affected by type B viral hepatitis. All these subjects have been treated with two injections of specific immunoglobulins at the dose of 0.06 ml/kg. i.m.; the first was administered immediately after contamination and the second after one month. Serum antibody titres were determined by RIA techniques in a six months follow-up. The results seem to indicate that the degree of protectivity after passive immunization is poor and rather incostant.

Female↗

PubMed1980